Fairmount Funds Management Llc Cogent Biosciences, Inc. (COGT) insider trading activity

COGT Quotes by TradingView

Fairmount Funds Management LLC Transaction History

Date Transaction Value Shares Traded Form
Jun 10 2024
BUY
Exercise of conversion of derivative security
-
1,500,000
Mar 28 2024
SELL
Other acquisition or disposition
-
286,851
Mar 28 2024
BUY
Other acquisition or disposition
-
286,851
Feb 16 2024
BUY
Grant, award, or other acquisition
$8,749,995 $7.5 p/Share
1,166,666
Jun 09 2023
BUY
Open market or private purchase
$9,600,000 $12.0 p/Share
800,000
Jun 16 2022
BUY
Open market or private purchase
$9,900,000 $8.25 p/Share
1,200,000
Jul 06 2020
BUY
Other acquisition or disposition
-
6,235,903

Also insider at

VRDN
Viridian Therapeutics, Inc.\DE Healthcare
Director
APGE
Apogee Therapeutics, Inc.
Director
MGTA
Magenta Therapeutics, Inc. Healthcare
Director
AGLE
Aeglea BioTherapeutics, Inc. Healthcare
ABIO
ARCA biopharma, Inc. Healthcare
Director
ZBIO
Zenas BioPharma, Inc.
Director
FFM

Fairmount Funds Management LLC

Philadelphia, PA

Track Institutional and Insider Activities on COGT

Follow Cogent Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells COGT shares.

Notify only if

Insider Trading

Get notified when an Cogent Biosciences, Inc. insider buys or sells COGT shares.

Notify only if

News

Receive news related to Cogent Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on COGT